| Field | Row 1 |
|---|---|
| adsh | 0001012477-25-000016 |
| cik | 1012477 |
| name | AVADEL PHARMACEUTICALS PLC |
| sic | 2834 |
| countryba | IE |
| stprba | |
| cityba | DUBLIN |
| zipba | 15 |
| bas1 | BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK |
| bas2 | BALLYCOOLIN |
| baph | 636-449-1830 |
| countryma | US |
| stprma | MO |
| cityma | CHESTERFIELD |
| zipma | 63005 |
| mas1 | 16640 CHESTERFIELD GROVE ROAD |
| mas2 | SUITE 200 |
| countryinc | |
| stprinc | |
| ein | 000000000 |
| former | FLAMEL TECHNOLOGIES SA |
| changed | 19960422 |
| afs | 1-LAF |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250507 |
| accepted | 2025-05-07 09:21:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | avdl-20250331_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001012477-25-000016 | 20241231 | Accounts Payable Current | 7328000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | -24580000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Additional Paid In Capital Common Stock | 891791000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 56370000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Common Stock Shares Issued | 96518000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Common Stock Shares Outstanding | 96518000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Cost Of Goods And Services Sold | 5577000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Depreciation And Amortization | 541000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Earnings Per Share Diluted | -0.0500 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Goodwill | 16836000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -4842000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -4842000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001012477-25-000016 | 20240331 | Increase Decrease In Inventories | 1260000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Interest Expense Debt | 2238000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Inventory Net | 20298000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -589000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001012477-25-000016 | 20250331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -147000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Net Unrealized Investment Gain Loss; | ||
| 0001012477-25-000016 | 20250331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 268000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001012477-25-000016 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Prepaid Expense And Other Assets Current | 6036000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Proceeds From Sale Of Available For Sale Securities Debt | 17808000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Retained Earnings Accumulated Deficit | -799247000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 52511000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001012477-25-000016 | 20241231 | Shares Outstanding | 96518000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001012477-25-000016 | 20231231 | Stockholders Equity | 52000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001012477-25-000016 | 20241231 | Stockholders Equity | 73848000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Stockholders Equity | 17000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Net Unrealized Investment Gain Loss; | ||
| 0001012477-25-000016 | 20250331 | Stockholders Equity | 966000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001012477-25-000016 | 20240331 | Stock Issued During Period Shares Employee Stock Ownership Plan | 48000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001012477-25-000016 | 20240331 | Stock Issued During Period Shares New Issues | 640000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001012477-25-000016 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | -52000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001012477-25-000016 | 20240331 | Stock Issued During Period Value Employee Stock Purchase Plan | 584000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Stock Issued During Period Value New Issues | 6000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001012477-25-000016 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 282000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Additional Paid In Capital Common Stock | 896663000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 5389000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Cash And Cash Equivalents At Carrying Value | 56370000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Common Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Comprehensive Income Net Of Tax | -4652000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Cost Of Goods And Services Sold | 1522000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001012477-25-000016 | 20250331 | Earnings Per Share Basic | -0.0500 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Increase Decrease In Accrued Liabilities | 3415000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Increase Decrease In Accrued Liabilities | 218000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Increase Decrease In Other Noncurrent Assets And Liabilities Net | -179000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Interest Expense Debt | 2592000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Investment Income Net | 1378000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001012477-25-000016 | 20250331 | Liabilities Current | 50933000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Marketable Securities Current | 10114000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Net Cash Provided By Used In Investing Activities | 21387000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Net Cash Provided By Used In Operating Activities | -29704000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Operating Expenses | 51691000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001012477-25-000016 | 20250331 | Operating Expenses | 49935000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Operating Income Loss | -3001000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001012477-25-000016 | 20241231 | Operating Lease Liability Noncurrent | 1122000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Operating Lease Right Of Use Asset | 2896000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Other Liabilities Noncurrent | 5183000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Research And Development Expense | 4354000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Stockholders Equity | -23756000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001012477-25-000016 | 20240331 | Stockholders Equity | -24357000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Translation Adjustment; | ||
| 0001012477-25-000016 | 20250331 | Stockholders Equity | -24312000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001012477-25-000016 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 60000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001012477-25-000016 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | 52000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001012477-25-000016 | 20240331 | Stock Issued During Period Value New Issues | 9250000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 3000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001012477-25-000016 | 20241231 | Accounts Receivable Net Current | 34097000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Assets Current | 139258000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 35794000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Common Stock Shares Authorized | 500000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Comprehensive Income Net Of Tax | -27931000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 224000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Goodwill | 16836000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Income Tax Expense Benefit | 93000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Increase Decrease In Accounts Payable | 7528000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Increase Decrease In Accounts Receivable | 7484000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Increase Decrease In Other Noncurrent Assets And Liabilities Net | 585000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 3016000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Interest Expense Debt | 10830000.0000 | USD | 4 | us-gaap/2024 | Longterm Debt Type= Royalty Financing; | ||
| 0001012477-25-000016 | 20250331 | Interest Expense Debt | 2238000.0000 | USD | 1 | us-gaap/2024 | Longterm Debt Type= Royalty Financing; | ||
| 0001012477-25-000016 | 20241231 | Liabilities Current | 48834000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Operating Expenses | 51691000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Operating Income Loss | -26035000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001012477-25-000016 | 20250331 | Operating Lease Liability Noncurrent | 2189000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Other Liabilities Noncurrent | 5239000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Preferred Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Research And Development Expense | 3068000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Research And Development Expense | 4354000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001012477-25-000016 | 20231231 | Shares Outstanding | 5194000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001012477-25-000016 | 20231231 | Stockholders Equity | 898000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001012477-25-000016 | 20240331 | Stockholders Equity | 874018000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001012477-25-000016 | 20240331 | Stockholders Equity | -772838000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001012477-25-000016 | 20241231 | Stockholders Equity | 164000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Net Unrealized Investment Gain Loss; | ||
| 0001012477-25-000016 | 20241231 | Stockholders Equity | -24580000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001012477-25-000016 | 20250331 | Stockholders Equity | -24329000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Translation Adjustment; | ||
| 0001012477-25-000016 | 20250331 | Stockholders Equity | 896663000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001012477-25-000016 | 20240331 | Stock Issued During Period Value Employee Stock Purchase Plan | 1000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001012477-25-000016 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 3356000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 281000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001012477-25-000016 | 20250331 | Accrued Liabilities Current | 40917000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | 3000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001012477-25-000016 | 20250331 | Assets | 167949000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Cash And Cash Equivalents At Carrying Value | 51371000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 51371000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Common Stock Value | 966000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Cost Of Goods And Services Sold | 1522000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -246000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Gross Profit | 46934000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001012477-25-000016 | 20250331 | Increase Decrease In Accounts Payable | 1779000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Interest Expense Debt | 2592000.0000 | USD | 1 | us-gaap/2024 | Longterm Debt Type= Royalty Financing; | ||
| 0001012477-25-000016 | 20250331 | Interest Paid Net | 1890000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Inventory Net | 20406000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Investment Income Net | 397000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Liabilities | 93879000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Marketable Securities Current | 22406000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | 415000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Payments To Acquire Marketable Securities | 5491000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Preferred Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Proceeds From Issuance Of Common Stock | 9250000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Proceeds From Issuance Of Common Stock | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 3940000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 690000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Proceeds From Sale Of Available For Sale Securities Debt | 119066000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Property Plant And Equipment Net | 307000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Share Based Compensation | 5389000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Share Based Compensation | 4183000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001012477-25-000016 | 20231231 | Stockholders Equity | 954000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Net Unrealized Investment Gain Loss; | ||
| 0001012477-25-000016 | 20240331 | Stockholders Equity | 78384000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Stockholders Equity | 960000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001012477-25-000016 | 20241231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001012477-25-000016 | 20250331 | Stock Issued During Period Value Employee Stock Purchase Plan | 408000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001012477-25-000016 | 20240331 | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | 3000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Assets | 164236000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 4627000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Common Stock Shares Issued | 96632000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Earnings Per Share Diluted | -0.3000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Gross Profit | 25656000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001012477-25-000016 | 20240331 | Interest Expense Debt | 2592000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001012477-25-000016 | 20240331 | Investment Income Net | 1378000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Net Cash Provided By Used In Financing Activities | 690000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Net Income Loss | -4920000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Operating Expenses | 49935000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001012477-25-000016 | 20250331 | Operating Income Loss | -3001000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Operating Lease Liability Current | 582000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Operating Lease Liability Current | 706000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Operating Lease Right Of Use Asset | 1702000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Other Assets Noncurrent | 8652000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Payments To Acquire Marketable Securities | 97679000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 27178000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 27178000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001012477-25-000016 | 20241231 | Royalty Financing Liability Noncurrent | 35249000.0000 | USD | 0 | 0001012477-25-000016 | |||
| 0001012477-25-000016 | 20250331 | Royalty Financing Liability Noncurrent | 35518000.0000 | USD | 0 | 0001012477-25-000016 | |||
| 0001012477-25-000016 | 20240331 | Selling General And Administrative Expense | 48623000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20231231 | Stockholders Equity | -23167000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001012477-25-000016 | 20250331 | Stockholders Equity | -799247000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001012477-25-000016 | 20250331 | Stock Issued During Period Shares Restricted Stock Award Gross | 8000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001012477-25-000016 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 91693000.0000 | shares | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 96601000.0000 | shares | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Accounts Payable Current | 9116000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Accrued Liabilities Current | 40651000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 4999000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Common Stock Shares Outstanding | 96632000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Cost Of Goods And Services Sold | 5577000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001012477-25-000016 | 20240331 | Earnings Per Share Basic | -0.3000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Gross Profit | 25656000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -27249000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Increase Decrease In Inventories | 66000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Liabilities | 90388000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Liabilities And Stockholders Equity | 167949000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Net Cash Provided By Used In Investing Activities | 12317000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Net Income Loss | -27342000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Net Income Loss | -4920000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001012477-25-000016 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -353000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Net Unrealized Investment Gain Loss; | ||
| 0001012477-25-000016 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -236000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Translation Adjustment; | ||
| 0001012477-25-000016 | 20250331 | Other Operating Activities Cash Flow Statement | 70000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Property Plant And Equipment Net | 453000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Selling General And Administrative Expense | 45581000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20231231 | Shares Outstanding | 89825000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001012477-25-000016 | 20240331 | Shares Outstanding | 96097000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001012477-25-000016 | 20240331 | Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001012477-25-000016 | 20231231 | Stockholders Equity | 87739000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20231231 | Stockholders Equity | -24121000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Translation Adjustment; | ||
| 0001012477-25-000016 | 20241231 | Stockholders Equity | -24744000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Translation Adjustment; | ||
| 0001012477-25-000016 | 20241231 | Stockholders Equity | -794328000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001012477-25-000016 | 20250331 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001012477-25-000016 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 390000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001012477-25-000016 | 20250331 | Stock Issued During Period Value Employee Stock Purchase Plan | 409000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 1000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001012477-25-000016 | 20241231 | Assets Current | 134208000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 31167000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Common Stock Shares Authorized | 500000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Common Stock Value | 965000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -27249000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001012477-25-000016 | 20240331 | Increase Decrease In Accounts Receivable | 10589000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Interest Expense Debt | 2238000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001012477-25-000016 | 20240331 | Interest Paid Net | 730000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Liabilities And Stockholders Equity | 164236000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Net Cash Provided By Used In Financing Activities | 13190000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Net Cash Provided By Used In Operating Activities | -8232000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Operating Income Loss | -26035000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Other Assets Noncurrent | 11037000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -589000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 268000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -353000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20241231 | Other Liabilities Current | 273000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Other Operating Activities Cash Flow Statement | -719000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Research And Development Expense | 3068000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001012477-25-000016 | 20241231 | Retained Earnings Accumulated Deficit | -794328000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 52511000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Shares Outstanding | 96632000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001012477-25-000016 | 20250331 | Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001012477-25-000016 | 20240331 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001012477-25-000016 | 20250331 | Stockholders Equity | 74070000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Stock Issued During Period Value Employee Stock Purchase Plan | 1000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001012477-25-000016 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 3353000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001012477-25-000016 | 20250331 | Accounts Receivable Net Current | 41581000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | -24312000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 5389000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001012477-25-000016 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 4183000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 4183000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001012477-25-000016 | 20250331 | Depreciation And Amortization | 825000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Gross Profit | 46934000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Income Tax Expense Benefit | 78000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 6082000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Investment Income Net | 397000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001012477-25-000016 | 20240331 | Net Income Loss | -27342000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001012477-25-000016 | 20240331 | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -236000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 415000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Translation Adjustment; | ||
| 0001012477-25-000016 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -147000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Other Liabilities Current | 194000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Prepaid Expense And Other Assets Current | 10787000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20231231 | Stockholders Equity | 855452000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001012477-25-000016 | 20231231 | Stockholders Equity | -745496000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001012477-25-000016 | 20240331 | Stockholders Equity | 601000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Net Unrealized Investment Gain Loss; | ||
| 0001012477-25-000016 | 20241231 | Stockholders Equity | 891791000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001012477-25-000016 | 20241231 | Stockholders Equity | 965000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001012477-25-000016 | 20240331 | Stock Issued During Period Shares Conversion Of Convertible Securities | 5194000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001012477-25-000016 | 20240331 | Stock Issued During Period Shares Conversion Of Convertible Securities | -5194000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001012477-25-000016 | 20250331 | Stock Issued During Period Shares Employee Stock Ownership Plan | 46000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001012477-25-000016 | 20240331 | Stock Issued During Period Value Employee Stock Purchase Plan | 583000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001012477-25-000016 | 20240331 | Stock Issued During Period Value New Issues | 9244000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001012477-25-000016 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 91693000.0000 | shares | 1 | us-gaap/2024 | |||
| 0001012477-25-000016 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 96601000.0000 | shares | 1 | us-gaap/2024 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Accounts Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenue from Contract with Customer, Excluding Assessed Tax | Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Depreciation And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization, Nonproduction | The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. |
| Stock Issued During Period Shares Restricted Stock Award Gross | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Restricted Stock Award, Gross | Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards. | |
| Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. |
| Accounts Receivable Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Other Operating Activities Cash Flow Statement | us-gaap/2024 | 0 | 0 | monetary | D | D | Other Operating Activities, Cash Flow Statement | Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities). |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Stock Issued During Period Shares Employee Stock Ownership Plan | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Employee Stock Ownership Plan | Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan. | |
| Stock Issued During Period Value Conversion Of Convertible Securities | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Conversion of Convertible Securities | The gross value of stock issued during the period upon the conversion of convertible securities. |
| Stock Issued During Period Value Employee Stock Purchase Plan | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Employee Stock Purchase Plan | Aggregate change in value for stock issued during the period as a result of employee stock purchase plan. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Royalty Financing Liability Noncurrent | 0001012477-25-000016 | 1 | 0 | monetary | I | C | Royalty Financing Liability, Noncurrent | Royalty Financing Liability, Noncurrent |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Cost Of Goods And Services Sold | us-gaap/2024 | 0 | 0 | monetary | D | D | Cost of Goods and Services Sold | The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | D | D | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations | Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Gross Profit | us-gaap/2024 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised | Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised. |
| Stock Issued During Period Shares Conversion Of Convertible Securities | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Conversion of Convertible Securities | Number of shares issued during the period as a result of the conversion of convertible securities. | |
| Increase Decrease In Inventories | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Inventories | The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
| Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | us-gaap/2024 | 0 | 0 | monetary | D | D | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Marketable Securities Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Marketable Securities, Current | Amount of investment in marketable security, classified as current. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Selling General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Selling, General and Administrative Expense | The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Interest Expense Debt | us-gaap/2024 | 0 | 0 | monetary | D | D | Interest Expense, Debt | Amount of the cost of borrowed funds accounted for as interest expense for debt. |
| Other Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Current | Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Goodwill | us-gaap/2024 | 0 | 0 | monetary | I | D | Goodwill | Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. |
| Increase Decrease In Other Noncurrent Assets And Liabilities Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net | Amount of increase (decrease) in noncurrent operating assets after deduction of noncurrent operating liabilities classified as other. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Other Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Inventory Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Inventory, Net | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | Amount after tax of other comprehensive income (loss) attributable to parent entity. |
| Increase Decrease In Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
| Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Additional Paid In Capital Common Stock | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Investment Income Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Investment Income, Net | Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent | Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Proceeds From Sale Of Available For Sale Securities Debt | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale of Debt Securities, Available-for-Sale | Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Payments To Acquire Marketable Securities | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Marketable Securities | Amount of cash outflow for purchase of marketable security. |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Proceeds From Issuance Of Common Stock | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
| Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | |
| Stock Issued During Period Value New Issues | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax | us-gaap/2024 | 0 | 0 | monetary | D | D | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax | Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001012477-25-000016 | 2 | 1 | IS | 0 | H | Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | Net product revenue | 0 |
| 0001012477-25-000016 | 2 | 2 | IS | 0 | H | Cost Of Goods And Services Sold | us-gaap/2024 | Cost of products sold | 0 |
| 0001012477-25-000016 | 2 | 3 | IS | 0 | H | Gross Profit | us-gaap/2024 | Gross profit | 0 |
| 0001012477-25-000016 | 2 | 5 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development expenses | 0 |
| 0001012477-25-000016 | 2 | 6 | IS | 0 | H | Selling General And Administrative Expense | us-gaap/2024 | Selling, general and administrative expenses | 0 |
| 0001012477-25-000016 | 2 | 7 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expense | 0 |
| 0001012477-25-000016 | 2 | 8 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Operating loss | 0 |
| 0001012477-25-000016 | 2 | 9 | IS | 0 | H | Investment Income Net | us-gaap/2024 | Investment and other income, net | 0 |
| 0001012477-25-000016 | 2 | 10 | IS | 0 | H | Interest Expense Debt | us-gaap/2024 | Interest expense | 1 |
| 0001012477-25-000016 | 2 | 11 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Loss before income taxes | 0 |
| 0001012477-25-000016 | 2 | 12 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Income tax provision | 0 |
| 0001012477-25-000016 | 2 | 13 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001012477-25-000016 | 2 | 14 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per share - basic (in dollars per share) | 0 |
| 0001012477-25-000016 | 2 | 15 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per share - diluted (in dollars per share) | 0 |
| 0001012477-25-000016 | 2 | 16 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average number of shares outstanding - basic (in shares) | 0 |
| 0001012477-25-000016 | 2 | 17 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted average number of shares outstanding - diluted (in shares) | 0 |
| 0001012477-25-000016 | 3 | 1 | CI | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001012477-25-000016 | 3 | 3 | CI | 0 | H | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2024 | Foreign currency translation income (loss) | 0 |
| 0001012477-25-000016 | 3 | 4 | CI | 0 | H | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2024 | Net other comprehensive loss, net of income tax expense of $0 and $0, respectively | 0 |
| 0001012477-25-000016 | 7 | 26 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Ending balance (in shares) | 0 |
| 0001012477-25-000016 | 3 | 5 | CI | 0 | H | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2024 | Total other comprehensive income (loss), net of tax | 0 |
| 0001012477-25-000016 | 3 | 6 | CI | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Total comprehensive loss | 0 |
| 0001012477-25-000016 | 4 | 1 | CI | 1 | H | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax | us-gaap/2024 | Net other comprehensive (loss) income, tax expense | 1 |
| 0001012477-25-000016 | 5 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001012477-25-000016 | 5 | 4 | BS | 0 | H | Marketable Securities Current | us-gaap/2024 | Marketable securities | 0 |
| 0001012477-25-000016 | 5 | 5 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2024 | Accounts receivable, net | 0 |
| 0001012477-25-000016 | 5 | 6 | BS | 0 | H | Inventory Net | us-gaap/2024 | Inventories | 0 |
| 0001012477-25-000016 | 5 | 7 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0001012477-25-000016 | 5 | 8 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001012477-25-000016 | 5 | 9 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
| 0001012477-25-000016 | 5 | 10 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right-of-use assets | 0 |
| 0001012477-25-000016 | 5 | 11 | BS | 0 | H | Goodwill | us-gaap/2024 | Goodwill | 0 |
| 0001012477-25-000016 | 5 | 12 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2024 | Other non-current assets | 0 |
| 0001012477-25-000016 | 5 | 13 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0001012477-25-000016 | 5 | 16 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Current portion of operating lease liability | 0 |
| 0001012477-25-000016 | 5 | 17 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0001012477-25-000016 | 5 | 18 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2024 | Accrued expenses | 0 |
| 0001012477-25-000016 | 5 | 19 | BS | 0 | H | Other Liabilities Current | us-gaap/2024 | Other current liabilities | 0 |
| 0001012477-25-000016 | 5 | 20 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001012477-25-000016 | 5 | 21 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Long-term operating lease liability | 0 |
| 0001012477-25-000016 | 5 | 22 | BS | 0 | H | Royalty Financing Liability Noncurrent | 0001012477-25-000016 | Royalty financing obligation | 0 |
| 0001012477-25-000016 | 5 | 23 | BS | 0 | H | Other Liabilities Noncurrent | us-gaap/2024 | Other non-current liabilities | 0 |
| 0001012477-25-000016 | 5 | 24 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0001012477-25-000016 | 5 | 26 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred shares, nominal value of $0.01 per share; 50,000 shares authorized; zero issued and outstanding at March 31, 2025 and December 31, 2024 | 0 |
| 0001012477-25-000016 | 5 | 27 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Ordinary shares, nominal value of $0.01 per share; 500,000 shares authorized; 96,632 issued and outstanding at March 31, 2025 and 96,518 issued and outstanding at December 31, 2024 | 0 |
| 0001012477-25-000016 | 5 | 28 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001012477-25-000016 | 5 | 29 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001012477-25-000016 | 5 | 30 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive loss | 0 |
| 0001012477-25-000016 | 5 | 31 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total shareholders equity | 0 |
| 0001012477-25-000016 | 5 | 32 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and shareholders equity | 0 |
| 0001012477-25-000016 | 6 | 1 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred shares, nominal value (in dollars per share) | 0 |
| 0001012477-25-000016 | 6 | 2 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred shares, shares authorized (in shares) | 0 |
| 0001012477-25-000016 | 6 | 3 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred shares, shares issued (in shares) | 0 |
| 0001012477-25-000016 | 6 | 4 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred shares, shares outstanding (in shares) | 0 |
| 0001012477-25-000016 | 6 | 5 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Ordinary shares, nominal value (in dollars per share) | 0 |
| 0001012477-25-000016 | 6 | 6 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Ordinary shares, shares authorized (in shares) | 0 |
| 0001012477-25-000016 | 6 | 7 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Ordinary shares, shares issued (in shares) | 0 |
| 0001012477-25-000016 | 6 | 8 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Ordinary shares, shares outstanding (in shares) | 0 |
| 0001012477-25-000016 | 7 | 11 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Beginning balance (in shares) | 0 |
| 0001012477-25-000016 | 7 | 12 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning balance | 0 |
| 0001012477-25-000016 | 7 | 13 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001012477-25-000016 | 7 | 14 | EQ | 0 | H | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2024 | Other comprehensive income (loss) | 0 |
| 0001012477-25-000016 | 7 | 15 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Issuance of common stock, net of issuance costs (in shares) | 0 |
| 0001012477-25-000016 | 7 | 16 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Issuance of common stock, net of issuance costs | 0 |
| 0001012477-25-000016 | 7 | 17 | EQ | 0 | H | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | us-gaap/2024 | Amortization of deferred issuance costs | 1 |
| 0001012477-25-000016 | 7 | 18 | EQ | 0 | H | Stock Issued During Period Shares Conversion Of Convertible Securities | us-gaap/2024 | Conversion of preferred stock into ordinary shares (in shares) | 0 |
| 0001012477-25-000016 | 7 | 19 | EQ | 0 | H | Stock Issued During Period Value Conversion Of Convertible Securities | us-gaap/2024 | Conversion of preferred stock into ordinary shares | 0 |
| 0001012477-25-000016 | 7 | 20 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | Exercise of stock options (in shares) | 0 |
| 0001012477-25-000016 | 7 | 21 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | Exercise of stock options | 0 |
| 0001012477-25-000016 | 7 | 22 | EQ | 0 | H | Stock Issued During Period Shares Restricted Stock Award Gross | us-gaap/2024 | Vesting of restricted shares (in shares) | 0 |
| 0001012477-25-000016 | 7 | 23 | EQ | 0 | H | Stock Issued During Period Shares Employee Stock Ownership Plan | us-gaap/2024 | Employee share purchase plan share issuance (in shares) | 0 |
| 0001012477-25-000016 | 7 | 24 | EQ | 0 | H | Stock Issued During Period Value Employee Stock Purchase Plan | us-gaap/2024 | Employee share purchase plan share issuance | 0 |
| 0001012477-25-000016 | 7 | 25 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Share-based compensation expense | 0 |
| 0001012477-25-000016 | 7 | 27 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending balance | 0 |
| 0001012477-25-000016 | 8 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001012477-25-000016 | 8 | 4 | CF | 0 | H | Depreciation And Amortization | us-gaap/2024 | Depreciation and amortization | 0 |
| 0001012477-25-000016 | 8 | 5 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Share-based compensation expense | 0 |
| 0001012477-25-000016 | 8 | 6 | CF | 0 | H | Other Operating Activities Cash Flow Statement | us-gaap/2024 | Other adjustments | 0 |
| 0001012477-25-000016 | 8 | 8 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2024 | Accounts receivable | 1 |
| 0001012477-25-000016 | 8 | 9 | CF | 0 | H | Increase Decrease In Inventories | us-gaap/2024 | Inventories | 1 |
| 0001012477-25-000016 | 8 | 10 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other current assets | 1 |
| 0001012477-25-000016 | 8 | 11 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Accounts payable & other current liabilities | 0 |
| 0001012477-25-000016 | 8 | 12 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2024 | Accrued expenses | 0 |
| 0001012477-25-000016 | 8 | 13 | CF | 0 | H | Increase Decrease In Other Noncurrent Assets And Liabilities Net | us-gaap/2024 | Other assets and liabilities | 1 |
| 0001012477-25-000016 | 8 | 14 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0001012477-25-000016 | 8 | 16 | CF | 0 | H | Proceeds From Sale Of Available For Sale Securities Debt | us-gaap/2024 | Proceeds from sales of marketable securities | 0 |
| 0001012477-25-000016 | 8 | 17 | CF | 0 | H | Payments To Acquire Marketable Securities | us-gaap/2024 | Purchases of marketable securities | 1 |
| 0001012477-25-000016 | 8 | 18 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash provided by investing activities | 0 |
| 0001012477-25-000016 | 8 | 20 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2024 | Proceeds from issuance of shares off the at-the-market offering program | 0 |
| 0001012477-25-000016 | 8 | 21 | CF | 0 | H | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | us-gaap/2024 | Proceeds from stock option exercises and employee share purchase plan | 0 |
| 0001012477-25-000016 | 8 | 22 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
| 0001012477-25-000016 | 8 | 23 | CF | 0 | H | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Effect of foreign currency exchange rate changes on cash and cash equivalents | 0 |
| 0001012477-25-000016 | 8 | 24 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net change in cash and cash equivalents | 0 |
| 0001012477-25-000016 | 8 | 25 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents at January 1, | 0 |
| 0001012477-25-000016 | 8 | 26 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents at March 31, | 0 |
| 0001012477-25-000016 | 8 | 28 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Interest paid | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |